This topic covers building, operating and validating secure generative-AI platforms for healthcare and other highly regulated industries. Based on the provided tool descriptions, it focuses on combining enterprise-grade models, agent orchestration, and governance/testing capabilities to protect sensitive data, meet regulatory obligations, and demonstrate audit-ready controls. Healthcare use cases (clinical summarization, decision support, patient messaging) and regulatory expectations (privacy, data residency, model risk management and explainability) make tightly governed GenAI deployments both high-value and high-risk in 2026. Key components and example tools: model and endpoint providers (Anthropic Claude family, Google Gemini, Mistral AI) supply conversational, multimodal and open/efficient foundation models; orchestration and assistant platforms (IBM watsonx Assistant, Microsoft 365 Copilot) enable no-code and developer-driven agents and integrations across workflows; infrastructure and observability layers (Xilos) claim comprehensive visibility into connected services and agentic activity. Together these layers must be paired with regulatory compliance tooling and GenAI test automation to validate data handling, prompt safety, provenance, and performance under audit. Current trends reflected here include the rise of agentic and multimodal assistants, greater demand for vendor options that support private and on-premise deployments, and an emphasis on continuous test automation and telemetry for governance. For regulated organizations the priority is not model capability alone but demonstrable controls: robust logging, access controls, synthetic-data testing, redact-and-mask pipelines, bias and safety tests, and reproducible audit trails. This topic helps practitioners evaluate how combinations of models, assistant platforms, and observability/compliance tooling fit into an enterprise architecture that meets both clinical and regulatory requirements.